PainReform Ltd. (PRFX): Price and Financial Metrics Recent IPO

PainReform Ltd. (PRFX) Recent IPO

Today's Latest Price: $4.50 USD

0.09 (-1.96%)

Updated Nov 24 3:55pm

Add PRFX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PRFX Stock Price Chart Interactive Chart >

Price chart for PRFX

PRFX Price/Volume Stats

Current price $4.50 52-week high $7.85
Prev. close $4.59 52-week low $4.03
Day low $4.41 Volume 69,100
Day high $4.64 Avg. volume 77,033
50-day MA $4.73 Dividend yield N/A
200-day MA $0.00 Market Cap 40.10M

PainReform Ltd. (PRFX) Company Bio

PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.

PRFX Latest News Stream

Event/Time News Detail
Loading, please wait...

PRFX Latest Social Stream

Loading social stream, please wait...

View Full PRFX Social Stream

Latest PRFX News From Around the Web

Below are the latest news stories about Painreform Ltd that investors may wish to consider to help them evaluate PRFX as an investment opportunity.

PainReform Seeks U.S. IPO For Phase 3 Trials

Quick Take PainReform Ltd. (PRFX) has filed to raise $25 million in an IPO of its ordinary shares, according to an F-1 registration statement. The firm is a clinical stage biopharma developing a treatment for post-operative pain relief. PRFX has produced solid Phase 2 trial results to-date. I'll provide an...

Donovan Jones on Seeking Alpha | July 15, 2020

Read More 'PRFX' Stories Here

PRFX Price Returns

1-mo -2.03%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.844 seconds.